Cyclic peptides are promising scaffolds
for drug development, attributable
in part to their increased conformational order compared to linear
peptides. However, when optimizing the target-binding or pharmacokinetic
properties of cyclic peptides, it is frequently necessary to “fine-tune”
their conformations, e.g., by imposing greater rigidity, by subtly
altering certain side chain vectors, or by adjusting the global shape
of the macrocycle. This review systematically examines the various
types of structural modifications that can be made to cyclic peptides
in order to achieve such conformational control.